Clinical Outcomes of Theruptor Novo in the Management of Infected Diabetic Foot Wounds: A Case series
Authors
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
Diabetic foot infections (DFIs) represent a serious complication of diabetes, often leading to lower extremity amputations and increased morbidity. Standard treatment protocols typically involve wound debridement, infection control, and optimized wound care. This case series examined the efficacy of Theruptor Novo, an antimicrobial wound dressing by Healthium Medtech, Bangalore, India, in treating three patients with chronic infected foot wounds, characterized by exposed bone and necrotic tissue. Weekly applications of the dressing, alongside conventional debridement and irrigation yielded significant wound contraction and complete epithelialization within 5 to 10 weeks for all patients. Theruptor Novo effectively prevented infections, facilitated wound healing, and promoted tissue regeneration, indicating its potential as a valuable adjunct in the management of DFIs, possibly decreasing the necessity for surgical interventions.
##plugins.themes.bootstrap3.article.details##
Copyright (c) 2025 Jayanthinathan S
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons License All articles published in Annals of Medicine and Medical Sciences are licensed under a Creative Commons Attribution 4.0 International License.
[1] Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022; 183:109119. doi: 10.1016/j.diabres.2021.109119
[2] Noor S, Zubair M, Ahmad J. Diabetic foot ulcer-A review on pathophysiology, classification and microbial etiology. Diabetes Metab Syndr Clin Res Rev. 2015;9(3):192-199. doi: 10.1016/j.dsx.2015.04.007
[3] Bader MS. Diabetic Foot Infection. Am Fam Physician. 2008;78(1):71-79. [Cited 2024 Jan 28]; https://www.aafp.org/pubs/afp/issues/2008/0701/p71.html
[4] Gupta R, Murthy KS, Bhagavan KR, Moharana AK, Rodrigues M, Ts D. Antimicrobial properties of Theruptor 3D-hydrocellular wound dressing: An in vitro study. Int J Surg Open. 2022; 46:100528. doi: 10.1016/j.ijso.2022.100528
[5] Rodrigues M, Varthya S, Sunderasan V, et al. Efficacy, Safety, and Cost-Effectiveness of Healthium Theruptor Versus 3M Tegaderm Versus Plain Gauze Dressing for Wound Dressings Used in Abdominal and Joint Surgeries: A Prospective, Multicentric, Randomized Study. Cureus. 2024;16(2): e53947. doi:10.7759/cureus.53947
[6] Sampath J. Superficial Partial Thickness Burns Treated using Theruptor Novo, a Novel Antimicrobial Dressing: A Case Report. J Clin Diagn Res. Published online 2024. doi:10.7860/JCDR/2024/71052.19715
[7] Pavan B. Theruptor Novo dressing for an infected diabetic foot ulcer: a case study. Int J Sci Rep. 2023;9(12):406-408. doi:10.18203/issn.2454-2156.IntJSciRep20233532
[8] Pavan B. Theruptor novo: wound dressing for diabetic foot ulcer. Int Surg J. 2023;10(12):2010-2012. doi:10.18203/2349-2902.isj20233535
[9] Kale SM. Theruptor Novo, a novel wound dressing in the management of infected diabetic foot ulcer: two case reports. Int J Adv Med. 2024;11(1):43-46. doi:10.18203/2349-3933.ijam20233888
[10] Kale SM. A Case Report on Theruptor Novo: An Antimicrobial Dressing in the Management of Venous Leg Ulcer. J Clin Diagn Res. Published online 2024. doi:10.7860/JCDR/2024/71056.19814